Barrow Neurological Institute - Home
Contact Us Career Opportunities
About Barrow Physician Directory Medical Specialities, Centers and Clinics Research and Clinical Trials Patient and Family Information Education Information

Mikayla's New Life

Excerpted from Menor, Catherine: Pushing Boundaries: Neurosurgery. Barrow 15(2): 2003,
and two stories written by Roman Gokhman

Mikayla with pediatric neurologist John Kerrigan, M.D., and
pediatric neurosurgeon Harold Rekate, M.D.

 

Sarah and Trevor first noticed Mikayla's strange behavior shortly after she was born. The infant would seem to startle, her eyes glazed and a crooked grin on her face. But it was not until she was two that doctors diagnosed the problem: seizures caused by a tumor on the hypothalamus at the bottom of her brain. "A hypothalamic hamartoma (HH)," they said. "There is nothing we can do."

The problem was that US neurosurgeons had been unsuccessful in removing enough of the tumors to stop the seizures. Yet, untreated, children with HH often experience increasingly severe seizures, rages and metal deterioration. Only one doctor--Jeffrey Rosenfeld, MD, of Australia--was having success with a new approach he developed. But he was an ocean away from the Mikayla's family's home in Oregon.

And so, night after night, Mikayla had seizures. "There was nothing I could do and I'd see them every day," says Sarah. "I'd pray, please give her one night without a seizure."

Aware of the terrible dilemma facing families like Mikayla's family, Barrow invited Dr. Rosenfeld to come to Phoenix to teach his technique. Dr. Rosenfeld spent two weeks in February 2003 working with a team headed by Harold Rekate, MD and Robert Spetzler, MD Afterward, Barrow established the first Hypothalamic Hamartoma Program in the US

Mikayla had surgery on August 4th. Her seizures are gone. "Hopefully, she'll never have another one," says Sarah, "and she'll be able to drive a car, have kids and live a normal life."

The following are two articles reprinted from articles written by Roman Gokhman, published in The News Review, Douglas County, Oregon, on July 22, 2003 and August 11, 2003.

 

July 22, 2003
A RISKY CHANCE AT LIFE: Mikayla, 4, prepares for experimental surgery to remove rare brain tumor
By Roman Gokhman

For the first time in her four-year life, Mikayla has a chance at a normal future -- a future free from daily seizures, probable brain damage, a dependence on others and an early death.

But her hopes, and those of her family, rest on experimental new brain surgery that some of her doctors say is risky at best, and possibly permanently damaging.

Mikayla has hypothalamic hamartoma, or HH, a rare condition caused by a non-cancerous tumor in the brain. Only a few hundred cases of the condition have been diagnosed worldwide -- five of which were in Oregon.

Although the tumor does not spread to other parts of the body, it causes plenty of damage and is difficult to remove. Mikayla's pediatricians told her parents, Sarah and Trevor, that brain surgery would do more harm than good.

Cooling off: Like any child on a hot day,
Mikayla finds a blow-up pool a relaxing
place to cool off as her mother, Sarah,
watches in the shade. At left is her
younger sister, Amiya, 3.

 

But through an online support group, Mikayla's parents heard of two Australian neurosurgeons who operated on and apparently cured several children with HH using an innovative brain surgery. In February 2002, the Australian doctors taught this procedure to two surgeons at Barrow Neurological Institute in Phoenix, Ariz.

At that point, Sarah knew she could not let her daughter suffer any longer. The surgery is now scheduled for July 29 in Phoenix.

A Danger Within
Mikayla's tumor, the size of a small strawberry, sits close to the hypothalamus, a tiny structure in the brain. The hypothalamus balances and regulates blood pressure, body temperature, fluid and electrolytes. It also controls appetite, vision, memory, general arousal, rage, aggression and embarrassment.

Hypothalamic hamartoma is caused by gene mutation that starts at conception.

HH tumors cause victims to have laughing seizures, behavior problems, early puberty and epilepsy. When the child reaches 4 to 10 years in age, the seizures become longer and more severe. At this stage the child may begin to mentally regress.

"She's pretty much like a normal kid -- right now," said Sarah. "Her future can change."

Mikayla is a pleasant 4-year-old, who enjoys riding her bike, playing tag and playing with her dolls and her new puppy.

"My mom likes to be a mom -- she already has two babies," Mikayla said, referring to herself and her 3-year-old sister, Amiya.

Sarah has sacrificed much for her daughter since she was born.

"I noticed something was funny from birth," Sarah said. "No one listened to me."

When she noticed Mikayla was making strange grunting noises, she took her to Roseburg pediatrician Aric Groshong. Because Mikayla did not exhibit the signs in front of him and the family was not overtly concerned at the time, the doctor advised her it was probably colic.

"When the lay person thinks about seizures, they think about the whole body shaking," Groshong said in a telephone interview. "It can be more subtle than that."

Groshong said Mikayla's seizures were unique because she was alert when she was experiencing them.

But by the time Mikayla was about 20 months old, her seizures appeared as bouts of laughter. Sarah recorded an episode on video and took it to Groshong, who immediately referred the patient to Roseburg neuroscience specialist Joel Daven.

"The videotape was dramatic I (the seizures) were so frequent," Daven said.

Two weeks after doctors viewed the tape, in June of 2000, an MRI revealed the tumor. The following morning the family drove to Doernbecher, and Sarah thought an operation was imminent.

"We had the whole weekend to ponder: Is she going to die, is she going to have chemotherapy?" she said.

But brain surgery was not in the cards.

"They said they wouldn't operate on her because it would do more harm than good," she said.

Innovative Surgery
Mikayla's parents thought they had run out of options after physicians at Doernbecher told them people with HH are expected to live through the seizures. But then they discovered a Web-based community of people who were either afflicted with the disorder or were related to those who were.

A Web site, called HHUGS (Hypothalamic Hamartoma, Uncontrollable Gelastic Epilepsy), was started in 1997 by Phoenix, Oregon, resident Carl Christy. It has 150 members from all over the globe.

While Christy is not a doctor -- he works for a home theater production company in Ashland -- Sarah said Christy knows more about HH than many physicians in the state.

Christy said only one to two out of every million children have the condition and that there have been only 200 to 300 diagnosed cases in the United States.

"It's a real tough thing to diagnose," he said. "We know they are out there."

He said he knows of five children with HH in Oregon, one of whom has already died.

"The support group is the best for all of us," Trevor said.

In February 2002, the hearts of all of the group's members were in Australia, where a 4-year-old Arizona boy with HH was about to go through a landmark operation. His operation was a success.

During a standard brain surgery the tumor would be attacked through the bottom of the brain -- the incision would be made in the nose or ears, which is the shortest route. It has not been successful with HH, because the surgeon could not see or remove the entire tumor.

Australian neurosurgeons Simon Harvey and Jeffrey Rosenfeld developed a new technique, which involves going in from the top of the head between the left and right halves of the brain.

"Most neurosurgeons did not believe that that could be done," said Phoenix, Arizona, neurosurgeon Harold Rekate, in a telephone interview. Rekate will operate on Mikayla.

Harvey and Rosenfeld had by that point completed about 30 such procedures, all with apparent success.

By the time of the Arizona boy's operation, Harvey and Rosenfeld were looking to teach their method to American surgeons. They found two willing participants at Barrow Neurological Institute in Phoenix, Arizona.  Dr. Rekate, the chief of pediatric neuroscience at BNI, and Robert Spetzler, the director of the institute -- who at first publicly said the approach was unproven -- were now willing to try.

In February 2003, the Australian doctors came to Phoenix and performed six surgeries, all of them successful.

"[Rosenfeld] showed me that it could be done with safety," Rekate said.

To date, 54 new-approach surgeries have been performed: 40 by the Australian doctors and 14 by Rekate and Spetzler.

Out of Rekate's 14 patients, 11 are seizure-free and only one has not seen dramatic improvements.

Not all physicians support this still-new procedure.

Daven, the Roseburg neurosurgeon, believes it is too risky.

"It's still experimental," he said. "The parents of the patients need to know this. We don't know enough about the long-term outcome of the patient."

There have been some complications. Rekate said patients stand to lose their short-term memory, lose the ability to control hunger and become obese. These functions are controlled by the hypothalamus. A hormone that controls urine production can also be damaged, making the patient thirsty all of the time and urinate constantly. This can be easily controlled by hormone supplements, but the other two side effects are not.

Critical Choices
Sarah and Trevor, both 25, had an important decision to make.

Mikayla has from three to 15 seizures every day -- 95 percent of the time she has one within minutes of falling asleep. While they do not always cause pain, they leave her physically spent, and there is the damage they can do in the future.

Mikayla has tried three different medications, one of which she had to take five times every day.

"They do damage too," Trevor said. "You use medications to stop the seizures I but she becomes a vegetable."

This for a child who her mother describes as outgoing and who "never wants to miss out on a thing."

Neither of her parents have gotten much rest for the past four years.

"If the kid's not sleeping right, you're not sleeping right," said Trevor , a hazardous materials specialist.

And through it, they have tried to keep up hope.

"I feel lucky it's not cancer and she doesn't have to go through radiation," Sarah said, adding she is looking forward to the time when she can enroll Mikayla in dance and gymnastics classes like any other child.

Mikayla will turn 5 years old on July 28 -- the day before her surgery. Pending a successful surgery, she will enter kindergarten next year.

"I want to play with my toys every day (after getting out of the hospital)," she said.

Her family held a party for her at her grandmother's house last weekend and are leaving for Phoenix Thursday. The surgery is expected to cost $150,000, and the family's insurance company is covering 80 percent of it.

Sarah and Trevor have not told Mikayla any of the specifics of the operation, but she knows that her head will be cut open and is nervous.

"She asked me if they were going to cut (the tumor) out with a knife," Sarah said.

But Mikayla also knows the benefits.

"I won't feel a thing," she said. "No more seizures."

 

August 11, 2003
GIRL OK AFTER SURGERY
by Roman Gokhman

So far, so good for 5-year-old Mikayla.

Almost two weeks after undergoing innovative brain surgery, she is recovering on schedule, according to Phoenix, Arizona, surgeon Harold Rekate. It is still too early to tell whether she is free of hypothalamic hamartoma, a rare degenerating condition caused by a non-cancerous brain tumor.

"Everything went as well as we could have hoped for Mikayla," said Rekate. "Her family and I are very happy. The outcome is really good."

Mikayla's mother, Sarah , said she is beyond being happy and excited.

"I'm just in shock -- it's like pinch me, I'm dreaming," Sarah said.

Rekate removed 75 to 80 percent of her tumor, which sat close to the hypothalamus, a tiny structure in her brain. The hypothalamus regulates blood pressure, body temperature, appetite, vision, memory and emotion. HH tumors cause victims to have laughing seizures, behavior problems, early puberty and epilepsy.

When a child reaches 4 to 10 years in age, the seizures become longer and more severe and she may begin to mentally regress. Only a few hundred cases of the condition have been diagnosed worldwide.

"In the first two days (after the surgery) she had some spells that might have been seizures, but since day three she has been seizure-free for the first time," Rekate said.

The family returned from Phoenix Aug. 9 and celebrated the successful surgery at Mikayla's grandmother's home.

Sarah said Mikayla has experienced some headaches, but no other side effects.

Mikayla's parents heard of the surgery through an online support group. Two Australian neurosurgeons had operated on and apparently cured several children with HH using a new method to remove most of the tumor.

Standard brain surgery has not been successful with HH, according to Rekate, because of the location of the tumor. The Australian technique involved going in from the top of the head between the left and right halves of the brain.

In 2002, the Australian doctors taught this procedure to Rekate, the chief of pediatric neuroscience at Barrow Neurological Institute in Phoenix.

Some doctors have said the experimental surgery is risky at best, and possibly permanently damaging. Patients stand to lose short-term memory, lose the ability to control hunger and become obese. These functions are controlled by the hypothalamus. Urine production can also be affected. This can be controlled by hormone supplements, but the other two side effects are not.

Prior to the operation, Mikayla had from three to 15 seizures every day -- 95 percent of the time she had one within minutes of falling asleep.

More time is needed to see how effective the surgery was. Rekate said she will continue to take medications for seizures and see neurologists for at least one year.

"There are no limitations on her activities at this point," Rekate said.

Mikayla will enter kindergarten this fall.

"It doesn't hurt," Mikayla said. "I'm all done."

 

UPDATE


Two years after surgery Mikayla is doing very well. She has no seizures and is not on any seizure medications aside from monthly injections of Lupron for precocious (early) puberty. She is normal in every way and is now going into the second grade. Mikayla loves school and always wants to do her best. She tries very hard, although her short term memory is lacking at times. Overall she does very well.